-
Macromolecules: Conjugate of saponin, oligonucleotide and galnac
Recently, Sapreme Technologies published two patent applications[1,2] around their ENDOSCAPE® platform, which […]
-
Introducing Petr Cermak: “Returning to Prague feels like coming back for the future.”
Our GMP-certified development and manufacturing site in Prague is expanding rapidly. […]
-
Symeres acquires Massachusetts-based Organix Inc., adding lipids expertise and creating a strategic foothold in the US market
We are happy and proud to announce the acquisition of Organix, […]
-
Symeres’ daughter company Admescope welcomes Leah Haydock
Admescope, part of the Symeres family, has provided tailor-made ADME-Tox services […]
-
Opening Innovation Centre Chemistry & Engineering
The Innovation Centre Chemistry & Engineering was opened on March 24th in Groningen. […]
-
Turning waste into sustainable scaffolds for synthesis
High-throughput screening is a powerful tool to start drug-discovery programs. The […]
-
Symeres welcomes Dr. André de Vries
At Symeres, we’re always looking to support our clients with novel […]
-
Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor:
In 2016, Stefan Krauss and Jo Waaler (University Hospital of Oslo, […]
-
Chiralix, a Symeres company
At Symeres, many passionate scientists are engaged in R&D projects with […]
-
C&ENs 10 Start-Ups to Watch
This week, the 2021 Chemical & Engineering News list of ‘10 […]
-
Expanding the toolbox: Resolving racemates
Symeres has quite a legacy when it comes to university collaborations. […]
-
From CRO client to CRO employee: An interview with Dr. Chris Teleha
While working in big pharma, Dr. Chris Teleha spent years working with CROs […]
Feel free to contact us!
Curious to know more about what can we do for you? Get in touch and let’s start a conversation.
